News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Flagship Pioneering Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Unknown transaction of 683,760 shares
@ $14.92, valued at
$10.2M
Unknown transaction of 113,960 shares
@ $14.92, valued at
$1.7M
|
|
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/13/2023 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 3,246,753 shares
@ $2.31, valued at
$7.5M
|
|
| 02/27/2023 |
4
| Flagship Pioneering Inc. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Bought 1,993,986 shares
@ $5.78, valued at
$11.5M
Bought 1,329,324 shares
@ $5.78, valued at
$7.7M
|
|
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/17/2022 |
3
| Flagship Pioneering Inc. (10% Owner) has filed a Form 3 on Axcella Health Inc. |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/07/2022 |
4
| Nutritional Health LTP Fund General Partner LLC (10% Owner) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Bought 2,912,748 shares
@ $3.15, valued at
$9.2M
Bought 5,825,495 shares
@ $3.15, valued at
$18.4M
|
|
| 06/01/2022 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Bought 4,383,561 shares
@ $1.46, valued at
$6.4M
Bought 1,095,890 shares
@ $1.46, valued at
$1.6M
Bought 1,369,863 shares
@ $1.46, valued at
$2M
Bought 6,849,315 shares
@ $1.46, valued at
$10M
Bought 13,698,630 shares
@ $1.46, valued at
$20M
|
|
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/05/2021 |
4
| Flagship Pioneering Inc. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Converted 1,088,470 shares
@ $0
Converted 5,896,386 shares
@ $0
Converted 8,396,825 shares
@ $0
Bought 220,588 shares
@ $17, valued at
$3.7M
Converted 970,588 shares
@ $0
Converted 4,852,943 shares
@ $0
Bought 661,764 shares
@ $17, valued at
$11.2M
Converted 1,323,529 shares
@ $0
Bought 294,117 shares
@ $17, valued at
$5M
Converted 4,112,000 convertible preferred
@ $0
Converted 22,275,232 convertible preferred
@ $0 |
|
| 08/05/2021 |
4
| Flagship Pioneering Inc. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Converted 1,088,470 shares
@ $0
Converted 5,896,386 shares
@ $0
Converted 8,396,825 shares
@ $0
Bought 220,588 shares
@ $17, valued at
$3.7M
Converted 970,588 shares
@ $0
Converted 4,852,943 shares
@ $0
Bought 661,764 shares
@ $17, valued at
$11.2M
Converted 1,323,529 shares
@ $0
Bought 294,117 shares
@ $17, valued at
$5M
Converted 4,112,000 convertible preferred
@ $0
Converted 22,275,232 convertible preferred
@ $0 |
|
| 07/29/2021 |
3
| Flagship Pioneering Inc. (10% Owner) has filed a Form 3 on Omega Therapeutics, Inc. |
| 07/29/2021 |
3
| Flagship Pioneering Inc. (10% Owner) has filed a Form 3 on Omega Therapeutics, Inc. |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/10/2021 |
4
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Converted 1,487,371 shares
@ $0
Converted 9,725,122 shares
@ $0
Converted 11,441,326 shares
@ $0
Converted 11,585,199 shares
@ $0
Converted 1,487,371 convertible preferred
@ $0
Converted 9,725,122 convertible preferred
@ $0
Converted 11,441,326 convertible preferred
@ $0
Converted 11,585,199 convertible preferred
@ $0 |
|
| 02/03/2021 |
3
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Sana Biotechnology, Inc. |
| 12/10/2020 |
4
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Converted 8,888,888 shares
@ $0
Converted 1,481,481 shares
@ $0
Converted 4,444,444 convertible preferred
@ $0
Converted 4,074,074 convertible preferred
@ $0
Converted 370,370 convertible preferred
@ $0
Converted 1,481,481 convertible preferred
@ $0 |
|
| 12/03/2020 |
3
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Sigilon Therapeutics, Inc. |
| 11/25/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Disposed of 3,587,820 shares
@ $0
Disposed of 642,180 shares
@ $0
Disposed of 966,234 shares
@ $0
Disposed of 1,186,310 shares
@ $0
Disposed of 1,481,481 shares
@ $0
Disposed of 43,154 shares
@ $0 |
|
| 11/16/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/29/2020 |
4
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Converted 4,054,054 shares
@ $0
Converted 4,504,504 shares
@ $0
Converted 722,320 shares
@ $0
Bought 50,000 shares
@ $16, valued at
$800k
Converted 1,441,441 shares
@ $0
Bought 50,000 shares
@ $16, valued at
$800k
Converted 1,801,801 shares
@ $0
Bought 50,000 shares
@ $16, valued at
$800k
Converted 7,500,000 convertible preferred
@ $0
Converted 8,333,333 convertible preferred
@ $0
Converted 1,336,293 convertible preferred
@ $0 |
|
| 10/22/2020 |
3
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Foghorn Therapeutics Inc. |
| 10/13/2020 |
3
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Codiak BioSciences, Inc. |
| 08/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/01/2020 |
3
| Nutritional Health LTP Fund General Partner LLC (10% Owner) has filed a Form 3 on Evelo Biosciences, Inc. |
| 05/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|
|
|